# Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

> **NCT01430611** · PHASE4 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 666 (actual)

## Conditions studied

- Meningococcal Disease
- Meningitis

## Interventions

- **BIOLOGICAL:** Meningococcal (Groups A and C) Polysaccharide Vaccine
- **BIOLOGICAL:** Meningococcal (Groups A and C) Polysaccharide Vaccine

## Key facts

- **NCT ID:** NCT01430611
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-11
- **Target enrollment:** 666 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430611, "Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01430611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*